Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00749268 · ClinicalTrials.gov registry record · Phase 4
AbsorbaTack Evaluation of Postoperative Pain Following Laparoscopic Hernia Repair
A Phase 4 study, sponsored by Medtronic - MITG.
- Completed
- Registry status
- Phase 4
- Development phase
- 216
- Enrollment target
NCT00749268 is a Phase 4 study that has completed, run by Medtronic - MITG. The registered enrollment target is 216 participants.
The verdict
NCT00749268, a Phase 4 study, has completed, sponsored by Medtronic - MITG.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 216 participants
- Enrollment target
Study Summary
The objective of this study is to assess pain that occurs following hernia repair that is related to mesh fixation. The study is designed to see if there is any difference in pain after surgery between absorbable and permanent methods of mesh fixation in inguinal and ventral hernia repair.
Interventions
- DEVICE AbsorbaTack
- DEVICE ProTack
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 216 participants |
| Start Date | 2008-10 |
| Est. Completion | 2012-11 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00749268
The ClinicalTrials.gov registry entry for NCT00749268 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 216 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic - MITG, which has 119 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which AbsorbaTack is the first listed.
NCT00749268 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00749268 about?
NCT00749268 is a clinical study titled "AbsorbaTack Evaluation of Postoperative Pain Following Laparoscopic Hernia Repair". The objective of this study is to assess pain that occurs following hernia repair that is related to mesh fixation. The study is designed to see if there is any difference in pain after surgery between absorbable and permanent methods of mesh fixation in inguinal and ventral hernia repair.
What is the current status of trial NCT00749268?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 216 participants. The study started on 2008-10. Estimated completion is 2012-11.
What interventions are being tested in trial NCT00749268?
The interventions under investigation include: AbsorbaTack (DEVICE), ProTack (DEVICE).
Who is sponsoring clinical trial NCT00749268?
This trial is sponsored by Medtronic - MITG, which has 119 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.